Seelos Therapeutics (NASDAQ:SEEL) shares are trading higher. Traders are circulating a Massachusetts General Hospital report titled 'Investigational drug SLS-005 (Trehalose) receives "May Proceed" notice and Central IRB approval for the HEALEY ALS Platform Trial.'
Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that the National Comprehensive Cancer Network® (NCCN) added REZUROCKTM (belumosudil) tablets to its NCCN Clinical Practice Guidelines in Oncology (NCCN